Low-cost EV maker e.GO eyes European, US expansion

Low-cost EV maker e.GO eyes European, US expansion

The first e.GO Life electric cars of e.GO Mobile AG are parked in front of the headquarters of the German e-car start-up during kick-off for the production of 30,000 yearly units in Aachen, Germany, May 9, 2019. REUTERS/Wolfgang Rattay/File photo Acquire Licensing Rights LONDON, Oct 20 (Reuters) – German electric vehicle maker Next.e.GO Mobile plans … Read more

SPAC to return remaining $533 million raise for Trump social media deal

SPAC to return remaining $533 million raise for Trump social media deal

The Truth social network logo is seen on a smartphone in front of a display of former U.S. President Donald Trump in this picture illustration taken February 21, 2022. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights NEW YORK, Oct 12 (Reuters) – Digital World Acquisition Corp (DWAC.O), the SPAC that plans to merge with former U.S. … Read more

SPAC shell games will keep hiding the ball

SPAC shell games will keep hiding the ball

NEW YORK, Oct 5 (Reuters Breakingviews) – As blank-check deals go, it hardly could have been much worse than Better. The online mortgage lender led by Vishal Garg unveiled plans in May 2021 to go public at a nearly $8 billion valuation by way of a special-purpose acquisition company, exuberantly telling investors it expected to … Read more

Digital World investors vote for extension to finish deal with Trump media firm

Digital World investors vote for extension to finish deal with Trump media firm

Republican presidential candidate and former U.S. President Donald Trump speaks as he campaigns at the Iowa State Fair in Des Moines, Iowa, U.S. August 12, 2023. REUTERS/Evelyn Hockstein/File Photo Acquire Licensing Rights NEW YORK, Sept 5 (Reuters) – Investors in Digital World Acquisition (DWAC.O) (DWAC), the blank-check acquisition company that plans to merge with former … Read more

Illumina cuts annual profit forecast as biotech funding woes linger

Illumina cuts annual profit forecast as biotech funding woes linger

The offices of gene sequencing company Illumina Inc are shown in San Diego, California January 11, 2016. REUTERS/Mike Blake/File Photo Aug 9 (Reuters) – Illumina Inc (ILMN.O) cut annual profit forecast, in a sign that a funding crunch among its biotech and pharmaceutical clients is expected to weigh on sales for its genetic testing tools … Read more